The Biden administration said it would have saved $6 billion had the new prices been in effect last year. Drugs (Pharmaceuticals), Prices (Fares, Fees and Rates), Medicare, Inflation Reduction Act of 2022, Biden, Joseph R Jr, Harris, Kamala D, Presidential Election of 2024, United States Politics and Government, Bristol Myers Squibb Company, AstraZeneca PLC, Eli Lilly and Company, AbbVie Inc, Amgen Inc, Boehringer Ingelheim GmbH, Johnson & Johnson, Merck & Company Inc, Novartis AG, Novo Nordisk A/S, Pfizer Inc The Biden administration said it would have saved $6 billion had the new prices been in effect last year. NYT > Business
Headlines